BIO-PHARMA LOGISTICS MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2025-2032)

Bio Pharma Logistics Market Trends  & Growth – 2025 to 2032

Bio-pharma Logistics Market is estimated to be valued at USD 110.98 Bn in 2025 and is expected to reach USD 206.82 Bn in 2032, exhibiting a compound annual growth rate (CAGR) of 9.3% from 2025 to 2032.

Key Takeaways

• On the basis of Type, Cold Chain Logistics dominates the marketdue to the critical need for temperature-controlled handling of biologics, vaccines, and high-value pharmaceutical products.
• On the basis of Service Type , Transportation acquires a significant of the service segment, with increasing investments in smart packaging and real-time tracking to ensure product integrity during transit.
• Based on Application, Biologics account for contributing a significant portion of share within the global share market, driven by the rise in personalized medicine and complex molecules. Demand is also growing for logistics support in prescribed drugs, OTC medicines, and raw materials.
• On the basis of Region, North America dominates the global share market by 33.5% in 2025, led by robust infrastructure, regulatory compliance, and advanced cold chain networks. Asia Pacific is the fastest-growing region due to biopharma expansion in China and India.

Market Overview

The Bio-Pharma Logistics Market plays a significant role in the worldwide healthcare supply chain through the assurance of secure, timely, and compliant transport and storage of biopharmaceutical products such as biologics, cell and gene therapies, vaccines, and temperature-sensitive drugs. These are typically challenging cold chain logistics with temperatures ranging as low as -80°C to preserve efficacy and integrity. The industry has seen dramatic growth because demand for biologics and personalized medicine is very sensitive to changes in the environment.

Current Events and Its Impact

Uncover macros and micros vetted on 75+ parameters: Get instant access to report

Role of AI (Artificial Intelligence) in Bio-Pharma Logistics Industry

AI plays a transformative role in the biopharma logistics market by improving efficiency, accuracy, and decision-making across various aspects of the supply chain. AI algorithms analyze historical data and trends to forecast demand, inventory needs, and potential supply chain disruptions. This helps companies plan more effectively, reduce stockouts, and avoid overstocking, ensuring optimal inventory levels. In April 2025, SkyCell teamed up with Microsoft to introduce SkyMind, an AI-powered solution aimed at optimizing pharmaceutical supply chains by enhancing efficiency, compliance, and decision-making. Leveraging the Azure OpenAI Service and seamlessly integrated into Microsoft Teams and Copilot, SkyMind represents a significant advancement in the digitalization of pharma logistics, an industry that is grappling with challenges like shipment disruptions and inefficiencies.

Segmental Insights

To learn more about this report, Download Free Sample

Bio-Pharma Logistics Market Insights, By Type

  Growing Introduction of Temperature Sensitive is Driving the Cold-Chain Logistics Segment Growth

The Bio-Pharma Logistics Market, By Type is segmented into two types, Cold chain logistics dominate the market due to the necessity of maintaining specific temperature ranges for biologics and vaccines. Innovations like the ALIVE module—a low-cost, IoT-enabled vaccine storage solution—are enhancing last-mile delivery by ensuring temperature control and remote monitoring, crucial for vaccine efficacy in remote areas.  Non-Cold Chain Logistics, this segment caters to pharmaceuticals stable at ambient temperatures. Recent developments, such as the UK's trial of "fridge-free" vaccines using thermostable technology, aim to reduce reliance on cold chain logistics, potentially transforming vaccine distribution by allowing storage at room temperature for extended periods.

Bio-Pharma Logistics Market Insights, By Service

Transportation Segment Dominates the Overall Market

Transportation services, including air, sea, and land, are tailored for temperature-sensitive products. Companies like Zipline have revolutionized delivery methods by using drones to transport medical supplies, including vaccines, to hard-to-reach areas, significantly reducing delivery times and wastage. Besides this, In February 2024, Zuellig Pharma is set to introduce the Volvo FE Electric truck for cold chain logistics in Taiwan. This electric truck offers minimal emissions, contributing to a cleaner environment, and helps reduce noise disruptions in urban areas. This is further positively influencing the bio-pharma logistics market forecast. Warehousing, specialized storage facilities equipped with temperature control systems are essential for maintaining product integrity. The integration of advanced technologies ensures that biologics and other sensitive pharmaceuticals are stored under optimal conditions throughout their shelf life.

Bio-Pharma Logistics Market Insights, By Application

Growing Demand for Personalized Medicine is Propelling the Growth of Biologics Segment

The demand for biologics logistics is high due to the rise in biologic drug development. Companies like Catalent have expanded their manufacturing capabilities to support the production and distribution of complex biologic therapies.Vaccine logistics have seen significant growth. Efforts to improve vaccine distribution include the development of thermostable vaccines and the use of drone deliveries to ensure timely and efficient transportation to various regions. 

The logistics of prescribed drugs involve ensuring timely delivery to pharmacies and healthcare facilities, maintaining the efficacy and safety of medications through controlled environments. OTC medicine logistics focus on widespread distribution networks to meet consumer demand, emphasizing efficiency and cost-effectiveness in the supply chain. Raw Materials and Bulk Pharmaceuticals, the transportation and storage of raw materials and bulk pharmaceuticals require stringent controls to prevent contamination and ensure quality, forming a critical component of the pharmaceutical manufacturing process.

Regional Insights

To learn more about this report, Download Free Sample

North America Bio-pharma Logistics Market Analysis and Trends

North America is expected to be the largest market for the bio-pharma logistics market during the forecast period, accounting for over 33.5% of the market share in 2025. The growth of the market in North America is due to the presence of major bio-pharma companies and a well-established cold chain network in the region. In anticipation of potential tariffs on pharmaceutical imports, U.S. companies significantly increased their imports of drugs and medical products. In March 2025, pharmaceutical imports surged to over $50 billion, with Ireland emerging as a primary supplier due to its robust pharmaceutical production infrastructure. This stockpiling reflects efforts to mitigate risks associated with potential trade barriers. This is further adding to the bio-pharma logistics market share.

  Asia Pacific Bio-pharma Logistics Market Trends

The Asia Pacific market is expected to be the fastest-growing bio-pharma market growth due to the rapidly growing bio-pharmaceutical industry and demand for cold chain logistics in emerging countries like China and India. For instance, according to an article published by the Voice of Healthcare, India is taking strategic actions to strengthen its pharmaceutical and medical technology sectors by revamping its logistics value chain. The Department of Pharmaceuticals has launched a study to assess the entire logistics ecosystem, from raw material sourcing to last-mile delivery, with the aim of identifying infrastructure gaps, addressing inefficiencies, and developing solutions to modernize logistics in both pharma and medtech. This is further expected to propel the bio pharma logistics market demand in the region.

India Bio-pharma Logistics Market Trends

 

India as a leading global pharmaceutical exporter by 2030 and further solidifying its status by 2047. Developed in collaboration with industry leaders and government stakeholders, the report evaluates India's current pharmaceutical landscape, identifies growth opportunities, and outlines key initiatives to enhance competitiveness. These initiatives include investing in innovation, strengthening manufacturing capabilities, and improving regulatory frameworks. The report underscores the importance of targeted investments and policy reforms to elevate India's role in the global pharmaceutical supply chain.

United States Bio-pharma Logistics Market Trends

 In the United States, the growth is driven by the increasing demand for temperature-sensitive biopharmaceuticals. With medicines requiring cold storage rising from 26% in 2017 to 35% in 2022, and projections indicating that approximately half of all new medicines in the next five years will necessitate cold storage and distribution, the U.S. market faces significant logistical challenges. The global expenditure on biopharma cold chain logistics is expected to reach $21.3 billion, up from $15.4 billion in 2018, underscoring the need for advanced cold chain networks and storage facilities. In the U.S., this translates to increased investments in specialized infrastructure and a shift towards more reliable and cost-effective transportation methods, such as sea shipping, to ensure the integrity and timely delivery of pharmaceutical products.

Bio-pharma Logistics Market Drivers:

Growing bio-pharmaceutical industry globally

The biopharmaceutical industry has been growing steadily over the past decade which is driven by the development of novel biologic drugs and therapies. The emergence of biologics such as monoclonal antibodies, recombinant proteins, and cell and gene therapies led to strong pipeline growth and new product approvals. This increased the need for temperature-controlled logistics in order to maintain product integrity during transportation and storage. For instance, in November 2022, Sarepta Therapeutics, Inc., a company focusing on precision genetic medicine for rare diseases, announced that the U.S. Food and Drug Administration (FDA) had accepted the company's Biologics License Application (BLA) to seek accelerated approval of SRP-9001 (delandistrogene moxeparvovec) for the treatment of ambulant individuals with Duchenne muscular dystrophy.

Technological advancements in cold chain logistics solutions

Cold chain logistics is an integral part of bio-pharma product distribution to maintain product stability and efficacy. Advances in cold chain technologies such as temperature-controlled packaging, real-time monitoring systems, GPS trackers, IoT integration, and automation are helping in enhancing supply chain visibility, security, and efficiency. Advanced freezing techniques such as cryogenic freezing offer optimal preservation for biologics. Innovation in packaging solutions such as vacuum insulated panels (VIPs) and phase change materials provide extended thermal protection. The adoption of these technologies enables the transportation of time- and temperature-sensitive bio-pharma shipments across global distances. Technology investments by logistics providers to upgrade cold chain infrastructure are supporting the growth of the bio-pharma logistics market.

Bio-pharma Logistics Market Trends:

Sustainable cold chain initiatives

In efforts to reduce the environmental impact of temperature-controlled bio-pharma supply chains, logistics providers are taking initiatives to deploy renewable energy in operations. Solar, wind or fuel cell powered facilities; energy efficient warehouses, green reefer trucks, and use of bio-based insulation are among the measures which are being adopted for sustainable cold chains. Carbon-neutral solutions are also being offered to customers. Emphasis on sustainability is prompting investments in eco-friendly supply chains, presenting an opportunity.

Bio-pharma Logistics Market Opportunities

Expansion in emerging markets

Emerging pharmaceutical markets in developing countries provide significant expansion opportunities for bio-pharma logistics market players. Markets such as China, India, Brazil, Mexico, and Indonesia, with their large populations, rising incomes, and increasing healthcare expenditure, offers great potential. Investments by bio-pharma companies in these markets to serve the growing demand and favorable policy reforms are attracting logistics infrastructure development. Local partnerships, distribution infrastructure, and value-added services aligned with specific market needs will be the key success factors. Logistics players can leverage global expertise to expand in fast-growing emerging pharma markets.

Market Report Scope

Bio Pharma Logistics Market Report Coverage

Recent Developments in Bio Pharma Logistics Market:

• In April 2025, UPS announced its plan to acquire Canada's AHG for $1.6 billion. AHG operates nine distribution centers and 22 branches across Canada, specializing in third-party logistics and temperature-sensitive transportation for the healthcare industry. This acquisition aims to bolster UPS's healthcare logistics operations and enhance its global cold chain capabilities.
• In March 2025, DHL announced its acquisition of U.S.-based pharmaceutical logistics firm CryoPDP. This strategic move aims to bolster DHL's presence in the pharmaceutical sector, enhancing its supply chain services for the life sciences and healthcare industry. CryoPDP specializes in shipping, storage, and packaging solutions tailored for pharmaceutical and biotech companies. The acquisition is expected to strengthen DHL's capabilities in temperature-controlled logistics, a critical component in the bio-pharmaceutical supply chain.
• In January 2025, FedEx launched FedEx Surround® in India, an advanced monitoring and intervention solution designed to redefine supply chain management. Built on near-real-time visibility, AI-powered predictive analytics, and advanced handling capabilities, FedEx Surround® provides businesses with unmatched shipment visibility, control, and reliability.
• In January 2023, UPS Healthcare, a healthcare logistics company; launched UPS Premier service for transporting high-value biopharma shipments. It offers proactive monitoring and faster delivery with dedicated specialists.

Analyst Opinion (Expert Opinion)

The Bio-Pharma Logistics Market is growing at a very fast pace because the demand for cutting-edge biologics, vaccines, and new therapies like cell and gene therapies is continuously on the rise worldwide. These types of medicines are extremely sensitive to the external environment conditions, especially temperature, and must be maintained at cold chain logistics facilities with extremely precise temperature control from manufacturing through delivery to patients.

Additionally, the rise of personalized medicine, typically by patient-specific preparations with limited shelf life, is also accelerating the demand for time-sensitive, high-integrity supply chain solutions. Since healthcare providers and pharmaceutical firms are investing more in such advanced therapies, the logistics service providers have to ramp up capabilities across specialized packaging, real-time monitoring, and regulatory compliance to ensure product efficacy and safety. Despite opportunity for growth, bio-pharma logistics is not without challenges. The expense of maintaining cold chain integrity—i.e., refrigeration machinery, insulated containers, and energy consumption—is considerable, which undermines profitability, particularly in shipping to remote or hard-to-reach regions.

Apart from this, operating in a highly regulated niche makes business more complex with countries and regions setting different standards for pharmaceutical transportation and warehousing. Companies like U.S. need compliance, where Compliance is being mandated by companies like FDA, EMA, and WHO to implement rigid documentation, temperature audit, and verified transport practice. Logistics companies are required to incur cost for latest technology like IoT-enabled sensors to track temperatures, AI-fuelled route planning, and blockchain-fuelled traceability systems to maintain competitive edges while offering safe, efficient, and compliant bio-pharmaceutical shipment.

Market Segmentation

• By Type
  • Cold Chain Logistics
  • Non-cold Chain Logistics
  • Others
• By Temperature Type
  • Frozen
  • Chilled
  • Ambient
  • Others
• By Service
  • Transportation
  • Warehousing
  • Packaging
  • Others
• By Application
  • Clinical Trials Logistics
  • Cell & Gene Therapy Logistics
  • Medical Device Logistics
  • Biological Products Logistics
  • Vaccine Logistics
  • Drug Logistics
  • Chemical Logistics
• By Region
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa
• Top companies in Bio-pharma Logistics Market
  • DHL
  • FedEx
  • UPS
  • DB Schenker
  • Kuehne + Nagel
  • SF Express
  • Kerry Logistics
  • Agility Logistics
  • VersaCold Logistics Services
  • Marken
  • Air Canada Cargo
  • CEVA Logistics
  • Sofrigam
  • Nordic Cold Storage
  • Biocair
  • United Parcel Service
  • Cavalier Logistics
  • LifeConEx
  • AirBridgeCargo Airlines
  • World Courier

Source

Primary Research Interviews from the Following Stakeholders

• Logistics heads at leading biopharma firms
• Supply chain directors at vaccine and biologics manufacturing companies
• Cold chain operations managers at 3PL providers
• Compliance officers managing GDP/GMP logistics for global pharmaceutical exporters
• Procurement managers for temperature-controlled packaging solutions
• Government health logistics administrators and vaccination program coordinators in Asia and Africa

Databases

• World Health Organization (WHO) 
• U.S. Food and Drug Administration (FDA) 
• European Medicines Agency (EMA) 
• India’s Ministry of Health & Family Welfare (MoHFW) 
• China Food and Drug Administration (CFDA) 
• OECD Health Statistics 
• World Bank Logistics Performance Index (LPI) 

Magazines & Journals

• Journal of Pharmaceutical Sciences (Elsevier)
• BioPharm International
• Pharmaceutical Technology Journal
• Journal of Controlled Release
• International Journal of Pharmaceutics
• Logistics Management
• Cold Chain Management Journal
• Journal of Supply Chain Management in Healthcare

News Outlets

• Reuters – Pharma and Biotech Logistics Developments
• Bloomberg – Biopharmaceutical Supply Chain Innovations
• Financial Times – Healthcare & Manufacturing Coverage
• The Economic Times (India) – Pharma and Cold Chain Expansion News
• SCMP (South China Morning Post) – Chinese Biopharma and Logistics Updates
• CNBC – Healthcare Supply Chain Coverage
• The Hindu BusinessLine – Biopharma and Cold Chain Infrastructure Reports

Associations

• Parenteral Drug Association (PDA) – Guidance on Cold Chain Logistics
• International Air Transport Association (IATA) – CEIV Pharma Certification Guidelines
• Pharmaceutical Cold Chain Interest Group (PCCIG) – Best Practices in Cold Logistics
• BioPhorum Operations Group (BPOG) – End-to-End Biopharma Supply Chain Collaboration
• Indian Drug Manufacturers’ Association (IDMA) – Domestic Pharma Logistics Standards
• Global Cold Chain Alliance (GCCA) – Temperature-Sensitive Transport Protocols

Public Domain Sources

• U.S. Department of Health and Human Services (HHS) 
• UNICEF 
• European Commission – DG SANTE 
• Ministry of Commerce (China) 
• Ministry of Health and Family Welfare (India) 
• World Bank – Gavi COVAX Supply Chain Briefs

Proprietary Elements

• CMI Data Analytics Tool, Proprietary CMI Existing Repository of information for last 8 years